Literature DB >> 18538659

Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25.

Erik Meulmeester1, Marion Kunze, He Hsuan Hsiao, Henning Urlaub, Frauke Melchior.   

Abstract

Vertebrates express two distinct families of SUMO proteins (SUMO1 and SUMO2/3) that serve distinct functions as posttranslational modifiers. Many proteins are modified specifically with SUMO1 or SUMO2/3, but the mechanisms for paralog selectivity are poorly understood. In a screen for SUMO2/3 binding proteins, we identified Ubiquitin Specific Protease 25 (USP25). USP25 turned out to also be a target for sumoylation, being more efficient with SUMO2/3. Sumoylation takes place within USP25's two ubiquitin interaction motifs (UIMs) that are required for efficient hydrolysis of ubiquitin chains. USP25 sumoylation impairs binding to and hydrolysis of ubiquitin chains. Both SUMO2/3-specific binding and sumoylation depend on a SUMO interaction motif (SIM/SBM). Seven amino acids in the SIM of USP25 are sufficient for SUMO2/3-specific binding and conjugation, even when taken out of structural context. One mechanism for paralog-specific sumoylation may, thus, involve SIM-dependent recruitment of SUMO1 or SUMO2/3 thioester-charged Ubc9 to targets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538659     DOI: 10.1016/j.molcel.2008.03.021

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  98 in total

1.  Insights into high affinity small ubiquitin-like modifier (SUMO) recognition by SUMO-interacting motifs (SIMs) revealed by a combination of NMR and peptide array analysis.

Authors:  Andrew T Namanja; Yi-Jia Li; Yang Su; Steven Wong; Jingjun Lu; Loren T Colson; Chenggang Wu; Shawn S C Li; Yuan Chen
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

2.  CD2AP regulates SUMOylation of CIN85 in podocytes.

Authors:  Irini Tossidou; Rainer Niedenthal; Malte Klaus; Beina Teng; Kirstin Worthmann; Benjamin L King; Kevin J Peterson; Hermann Haller; Mario Schiffer
Journal:  Mol Cell Biol       Date:  2011-12-27       Impact factor: 4.272

3.  Deubiquitylase, deSUMOylase, and deISGylase activity microarrays for assay of substrate preference and functional modifiers.

Authors:  Christian M Loch; Charles L Cuccherini; Craig A Leach; James E Strickler
Journal:  Mol Cell Proteomics       Date:  2010-10-18       Impact factor: 5.911

4.  SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.

Authors:  Julio C Bayona; Ernesto S Nakayasu; Marc Laverrière; Clemente Aguilar; Tiago J P Sobreira; Hyungwon Choi; Alexey I Nesvizhskii; Igor C Almeida; Juan J Cazzulo; Vanina E Alvarez
Journal:  Mol Cell Proteomics       Date:  2011-08-10       Impact factor: 5.911

5.  Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex.

Authors:  Volkan Sakin; Sebastian M Richter; He-Hsuan Hsiao; Henning Urlaub; Frauke Melchior
Journal:  J Biol Chem       Date:  2015-08-06       Impact factor: 5.157

Review 6.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

7.  SUMO takes control of a ubiquitin-specific protease.

Authors:  Firaz Mohideen; Christopher D Lima
Journal:  Mol Cell       Date:  2008-06-06       Impact factor: 17.970

8.  Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  EMBO J       Date:  2009-04-02       Impact factor: 11.598

Review 9.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

10.  Ubiquitin-family modifications of topoisomerase I in camptothecin-treated human breast cancer cells.

Authors:  Ragu Kanagasabai; Shujun Liu; Samir Salama; Edith F Yamasaki; Liwen Zhang; Kari B Greenchurch; Robert M Snapka
Journal:  Biochemistry       Date:  2009-04-14       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.